Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-16-017105
Filing Date
2016-09-28
Accepted
2016-09-28 17:21:46
Documents
72
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2016_dandritbiotech.htm 10-K 1811693
2 CERTIFICATION f10k2016ex31i_dandritbio.htm EX-31.1 24354
3 CERTIFICATION f10k2016ex31ii_dandritbio.htm EX-31.2 22945
4 CERTIFICATION f10k2016ex32i_dandritbio.htm EX-32.1 8027
5 GRAPHIC image_001.jpg GRAPHIC 69939
6 GRAPHIC image_002.jpg GRAPHIC 61693
7 GRAPHIC image_003.jpg GRAPHIC 34584
8 GRAPHIC image_004.jpg GRAPHIC 111096
9 GRAPHIC image_005.jpg GRAPHIC 52410
10 GRAPHIC image_006.jpg GRAPHIC 4097
11 GRAPHIC image_007.jpg GRAPHIC 6402
12 GRAPHIC report01.jpg GRAPHIC 30130
  Complete submission text file 0001213900-16-017105.txt   5196063

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE ddrt-20160630.xml EX-101.INS 567231
14 XBRL SCHEMA FILE ddrt-20160630.xsd EX-101.SCH 44514
15 XBRL CALCULATION FILE ddrt-20160630_cal.xml EX-101.CAL 53097
16 XBRL DEFINITION FILE ddrt-20160630_def.xml EX-101.DEF 106031
17 XBRL LABEL FILE ddrt-20160630_lab.xml EX-101.LAB 369164
18 XBRL PRESENTATION FILE ddrt-20160630_pre.xml EX-101.PRE 234283
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-54478 | Film No.: 161907768
SIC: 2834 Pharmaceutical Preparations